PONZ DE LEON, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 42.204
AS - Asia 18.513
EU - Europa 16.411
SA - Sud America 2.551
AF - Africa 324
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 18
Totale 80.051
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 41.665
GB - Regno Unito 7.279
SG - Singapore 6.168
CN - Cina 5.120
HK - Hong Kong 2.065
BR - Brasile 1.980
VN - Vietnam 1.679
IT - Italia 1.668
SE - Svezia 1.553
DE - Germania 1.435
UA - Ucraina 1.093
FI - Finlandia 981
TR - Turchia 876
BD - Bangladesh 721
RU - Federazione Russa 663
FR - Francia 621
KR - Corea 493
BG - Bulgaria 389
IN - India 349
CA - Canada 276
AR - Argentina 202
ID - Indonesia 153
IQ - Iraq 146
MX - Messico 144
NL - Olanda 126
JP - Giappone 116
EC - Ecuador 100
ZA - Sudafrica 97
IE - Irlanda 86
BE - Belgio 83
PK - Pakistan 83
ES - Italia 79
AE - Emirati Arabi Uniti 73
CO - Colombia 72
PL - Polonia 63
VE - Venezuela 59
CL - Cile 58
MY - Malesia 53
UZ - Uzbekistan 45
SA - Arabia Saudita 43
AT - Austria 41
MA - Marocco 39
PH - Filippine 38
NP - Nepal 36
RO - Romania 34
LT - Lituania 33
TN - Tunisia 33
EG - Egitto 32
KE - Kenya 30
DZ - Algeria 29
CZ - Repubblica Ceca 28
JO - Giordania 28
PY - Paraguay 28
TH - Thailandia 28
AZ - Azerbaigian 27
AU - Australia 23
TW - Taiwan 23
IL - Israele 20
PE - Perù 20
JM - Giamaica 18
PT - Portogallo 17
OM - Oman 16
CH - Svizzera 15
CR - Costa Rica 15
IR - Iran 15
KZ - Kazakistan 15
UY - Uruguay 14
AL - Albania 13
BO - Bolivia 13
DO - Repubblica Dominicana 13
BY - Bielorussia 12
DK - Danimarca 12
ET - Etiopia 11
EU - Europa 11
SY - Repubblica araba siriana 11
GE - Georgia 10
GR - Grecia 10
PR - Porto Rico 10
RS - Serbia 10
LB - Libano 9
MD - Moldavia 9
PS - Palestinian Territory 9
HN - Honduras 8
PA - Panama 8
SN - Senegal 8
TT - Trinidad e Tobago 8
GT - Guatemala 7
HR - Croazia 7
HU - Ungheria 7
KG - Kirghizistan 7
KW - Kuwait 7
LV - Lettonia 7
NZ - Nuova Zelanda 7
BA - Bosnia-Erzegovina 6
BZ - Belize 6
LK - Sri Lanka 6
NG - Nigeria 6
NI - Nicaragua 6
SV - El Salvador 6
A2 - ???statistics.table.value.countryCode.A2??? 5
Totale 79.935
Salva come PNG Salva come JPEG
Città #
Southend 5.521
Singapore 4.108
Fairfield 3.408
Ashburn 3.361
Santa Clara 3.314
Woodbridge 2.650
Jacksonville 2.222
Houston 2.220
Hong Kong 2.044
Chandler 1.835
Hefei 1.744
Dearborn 1.426
Ann Arbor 1.336
Wilmington 1.316
Seattle 1.293
Chicago 1.276
San Jose 1.259
Cambridge 1.116
Los Angeles 943
Beijing 918
Nyköping 895
London 862
Helsinki 579
The Dalles 548
Salt Lake City 544
Ho Chi Minh City 514
Princeton 486
Izmir 463
Seoul 451
Council Bluffs 425
Hanoi 408
Sofia 380
Modena 370
Eugene 367
San Diego 359
New York 341
Lauterbourg 299
Des Moines 289
Elk Grove Village 255
Buffalo 250
Tampa 240
Dallas 239
Moscow 224
Milan 221
Shanghai 193
São Paulo 160
Columbus 142
Sterling 138
Frankfurt am Main 136
Lancaster 127
Bremen 114
Munich 113
Miami 102
Grafing 101
Falls Church 99
Phoenix 96
Orem 93
Tokyo 93
Da Nang 88
Atlanta 81
Jakarta 79
Boardman 74
Guangzhou 72
Detroit 67
Dulles 66
Brussels 62
Haiphong 62
Norwalk 62
Rio de Janeiro 62
Rome 62
Dublin 61
Mexico City 59
Falkenstein 58
Fremont 57
Baghdad 56
Kunming 56
Chennai 55
Nanjing 54
Toronto 54
Brooklyn 52
Miano 51
Belo Horizonte 50
Montreal 49
Rochester 49
Kent 47
Denver 46
Kansas City 46
Philadelphia 46
Quito 46
Pittsburgh 43
Reading 43
Cardiff 42
Dhaka 40
Tashkent 40
Turku 40
Jinan 38
Ottawa 38
San Francisco 38
Boston 36
Curitiba 36
Totale 57.289
Salva come PNG Salva come JPEG
Nome #
Estimates of cancer burden in Italy 709
Surgical management of the duodenal manifestations of familial adenomatous polyposis 539
EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century 494
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 461
Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies. 456
Attenuated polyposis of the large bowel: a morphologic and molecular approach 444
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 444
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 438
Differentiated Thyroid Carcinoma (DTC) in a Young Woman with Peutz-Jeghers Syndrome: are these Two Conditions Associated? 436
Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. 432
Lymph node micrometastasis and survival of patients with Stage i (Dukes' A) colorectal carcinoma 425
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers 421
A two-locus model for hereditary non-polyposis colorectal cancer in Modena, Italy 412
Long-term survey of patients with curable colorectal cancer with specific reference to the quality of life. 410
Morphological and quantitative analysis of BCL6 expression in human colorectal carcinogenesis. 405
Cyclooxygenase-2 and Hypoxia-Inducible Factor-1 alpha protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis 402
Survival, surgical management and perioperative mortality of colorectal cancer in the 21-year experience of a specialised registry 401
An unusual case of familial adenomatous polyposis with very early symptom occurrence 399
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 395
Pattern of cell kinetics in colorectal mucosa of patients with different types of adenomatous polyps of the large bowel 394
K-ras and p53 mutations in human colorectal aberrant crypt foci 390
A genetic model for determining MSH2 and MLH1 carrier probabilities based on family history and tumor microsatellite instability. 390
Microsatellite instability in multiple colorectal tumors 387
Aetiology of colorectal cancer and relevance of monogenic inheritance. 381
IDENTIFICATION OF HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER IN THE GENERAL-POPULATION - THE 6-YEAR EXPERIENCE OF A POPULATION-BASED REGISTRY 381
Incidence, clinical features and possible etiology of early onset (≤40 years) colorectal neoplasms. 380
Molecular screening for Hereditary Non Polyposis Colorectal Cancer (HNPCC): a prospective, population-based study 380
Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome 375
The influence of age on colonic epithelial cell proliferation 374
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations 371
Argyrophilic nucleolar organizer regions and bromodeoxyuridine and h3-thymidine labelling indices in colorectal cancer 366
The cause of colorectal cancer 364
Aberrant crypt foci in patients with colorectal cancer 364
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 364
Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a Specialized cancer Registry 361
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 361
Relative role of APC and MUTYH mutations in the pathogenesis of familial adenomatous polyposis. 354
Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors 354
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 348
Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma 345
Matrix metalloproteinases 15 and 19 are stromal regulators of colorectal cancer development from the early stages 344
Survival analysis in families affected by hereditary non-polyposis colorectal cancer 340
Histology of aberrant crypt foci in the human colon 338
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study 337
Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts 336
Investigation of APC mutations in a Turkish familial adenomatous polyposis family by heterodublex analysis 334
Clinical features and colorectal cancer survival: an attempt to explain differences between two different Italian regions. 333
PLZF expression during colorectal cancer development and in normal colorectal mucosa according to body size, as marker of colorectal cancer risk. 332
First observation of microadenomas in the ileal mucosa of patients with familial adenomatous polyposis and colectomies 328
Biologic characterization of Hereditary Non-Polyposis Colorectal Cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters. 326
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 324
Small bowel carcinoma in hereditary nonpolyposis colorectal cancer 324
Th Inducing POZ-Kruppel Factor (ThPOK) Is a Key Regulator of the Immune Response since the Early Steps of Colorectal Carcinogenesis 323
Clinical outcome of low- and high-risk malignant colorectal polyps: results of a population-based study and meta-analysis of the available literature 323
Carcinoma papillare e Sindrome di Peutz-Jeghers: una rara associazione 322
Problems in the identification of hereditary nonpolyposis colorectal cancer in two families with late development of full-blown clinical spectrum 321
Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. 319
Clinical features of colorectal cancer patients in advanced age: a population-based approach 314
Effect of the selective expansion of cholic acid pool on bile lipid composition: possible mechanism of bile acid induced biliary cholesterol desaturation. 310
Cholesterol esterase activity of human intestinal mucosa 307
Microsatellite instability and colorectal cancer prognosis. 307
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary 307
Decrease in plasma tryptophan after a tryptophan-free amino acid solution. A comparison between cirrhotic and control subjects 306
Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer 305
Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis 304
Methylation pattern of different regions of the MLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer. 303
Stage I colorectal carcinoma: VEGF immunohistochemical expression, microvessel density, and their correlation with clinical outcome. 301
Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: A population-based study 301
Clinical features, frequency and prognosis of Dukes' a colorectal carcinoma: A population-based investigation 300
Cancer prevalence in Italian cancer registry areas: The ITAPREVAL study 299
Risk of colorectal polyps and of malignancies in asymptomatic carriers of mutations in the main DNA mismatch repair genes 295
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 295
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 292
Familial aggregation of tumors and detection of hereditary non-polyposis colorectal cancer in 3-year experience of 2 population-based colorectal-cancer registries 291
Clinical and molecular diagnosis of hereditary non-polyposis colorectal cancer: problems and pitfalls in an extended pedigree 290
Clinical and molecular features of attenuated adenomatous polyposis in northern Italy. 290
Infliximab-related hepatitis: discussion of a case and review of the literature. 286
Effects of acute changes of bile acid pool composition on biliary lipid secretion 283
A founder MLH1 mutation in families from the districts of Modena and Reggio-Emilia in northern Italy with hereditary non-polyposis colorectal cancer associated with protein elongation and instability. 280
Alteration of drug metabolism during cholestasis in man 279
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma. 279
Colorectal carcinoma in different age groups: A population based investigation 275
Analysis of mismatch repair gene mutations in Turkish HNPCC patients. 274
A case of pneumatosis cystoides intestinalis mimicking familial adenomatous polyposis 274
The perception of health-related quality of life in colon cancer patients during chemotherapy: differences between men and women 274
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 274
Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: A retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database 273
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 272
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 272
Disease presentation, treatment and survival for Italian colorectal cancer patients: a EUROCARE high resolution study 272
Peutz-Jeghers syndrome: a systematic review and recommendations for management 270
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis 270
I tumori in Italia. Rapporto 2011: La sopravvivenza dei pazienti oncologici in Italia 268
Risk of cancer revealed by follow-up of families with hereditary non-polyposis colorectal cancer: a population-based study 267
In response. Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability. 266
Antioxidant vitamins and colorectal adenoma 265
Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading. 264
Epithelial cell kinetics in the remaining colorectal mucosa after surgery for cancer of the large bowel 264
[Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients] 262
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 261
Totale 34.152
Salva come PNG Salva come JPEG
Categoria #
all - tutte 316.894
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 316.894
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.836 154 907 466 488 134 285 358 273 633 392 1.072 674
2022/20235.088 686 528 321 499 628 951 66 451 608 35 189 126
2023/20243.078 120 211 186 190 799 257 298 435 81 47 98 356
2024/202511.798 445 117 146 870 2.404 1.693 767 654 1.310 708 1.238 1.446
2025/202626.768 1.449 1.011 2.235 3.595 5.892 1.675 2.785 1.323 2.027 1.827 1.718 1.231
2026/2027637 637 0 0 0 0 0 0 0 0 0 0 0
Totale 80.317